Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHMP2A anticorps

L’anticorps Lapin Polyclonal anti-CHMP2A a été validé pour WB et ELISA. Il convient pour détecter CHMP2A dans des échantillons de Humain, Rat et Souris.
N° du produit ABIN7112645

Aperçu rapide pour CHMP2A anticorps (ABIN7112645)

Antigène

Voir toutes CHMP2A Anticorps
CHMP2A (Charged Multivesicular Body Protein 2A (CHMP2A))

Reactivité

  • 25
  • 20
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Rat, Souris

Hôte

  • 38
  • 2
Lapin

Clonalité

  • 40
Polyclonal

Conjugué

  • 10
  • 5
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CHMP2A est non-conjugé

Application

  • 31
  • 14
  • 13
  • 13
  • 9
  • 6
  • 3
  • 2
  • 1
Western Blotting (WB), ELISA
  • Fonction

    CHMP2A antibody

    Purification

    Immunogen affinity purified

    Pureté

    ≥95 % as determined by SDS-PAGE

    Immunogène

    chromatin modifying protein 2A

    Isotype

    IgG
  • Indications d'application

    WB: 1:500-1:2000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze / thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    -20°C for 12 months

    Date de péremption

    12 months
  • Antigène

    CHMP2A (Charged Multivesicular Body Protein 2A (CHMP2A))

    Autre désignation

    CHMP2A

    Sujet

    Synonyms: Charged multivesicular body protein 2a|Chromatin-modifying protein 2a (CHMP2a)|Putative breast adenocarcinoma marker BC-2|Vacuolar protein sorting-associated protein 2-1 (Vps2-1, hVps2-1)|CHMP2A|BC2|CHMP2

    Background: Probable core component of the endosomal sorting required for transport complex III(ESCRT-III) which is involved in multivesicular bodies(MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles(ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O,-I,-II and-III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis(PubMed:21310966). Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase(PubMed:26040712). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. (Microbial infection) The ESCRT machinery functions in topologically equivalent membrane fission events, such as the budding of enveloped viruses(HIV-1 and other lentiviruses). Involved in HIV-1 p6-and p9-dependent virus release.

    Poids moléculaire

    32 kDa

    ID gène

    27243

    UniProt

    O43633

    Pathways

    SARS-CoV-2 Protein Interactome
Vous êtes ici:
Chat with us!